The Russian direct investment Fund (RDIF) and the national welfare Fund of Kazakhstan "Samruk-Kazyna" JSC have agreed to cooperate in the fight against coronavirus and discuss the possibility of localization of production of the Russian vaccine in Kazakhstan, the message reads RDIF.
RDIF and "Samruk-Kazyna" signed a Memorandum on cooperation for combating coronavirus infection. Under the agreement, RDIF has already made Kazakhstan the first batch of the drug against the coronavirus, "Avidavit". In addition, the FUND "Samruk-Kazyna" JSC have agreed to cooperate in clinical trials, sourcing and manufacturing of a vaccine against coronavirus.
The Russian direct investment Fund (RDIF) in July is awaiting authorization for outpatient treatment from the coronavirus "Aviewer", after it can appear in pharmacies on prescription, told reporters the head of RDIF Kirill Dmitriev.
"It is important to understand that there is an important fact - not the drug to use for pregnant women and during pregnancy planning. This is a very well known fact about this drug, we are openly talking about it. It is therefore very important that when people will get in the pharmacies, they will get the prescription, and the doctor is obliged to talk to them, that they will not plan for your family during the adoption preparation", - he stressed.
A number of Latin American countries, Saudi Arabia and Bulgaria has purchased Russian drug for the treatment of a coronavirus, "Aviewer", said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"Aviewer" production RDIF and Chemrar may 29, received a registration certificate of Ministry of health of the Russian Federation and became the world's first drug against the coronavirus that contains the active substance "Favipiravir", and on 3 June was included in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. "Aviewer" has proven its effectiveness in clinical trials and blocking mechanisms for the propagation of the coronavirus.
Regulatory approval of the vaccine for coronavirus is expected in August and September, said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"We are now actively working to start vaccine Institute Gamalei. Believe that is certainly extremely important. ...We believe that regulatory approval of the vaccine will be already in August-September," - said Dmitriev on air of TV channel "Russia 1".
Russian anti-coronavirus "avitamin a" better American "Ramdevpir", it is cheaper and comes in tablets, said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"Aviewer", in which participated the FUND, may 29, received a registration certificate of Ministry of health of the Russian Federation and became the world's first drug against the coronavirus that contains active substance favipiravir, and on 3 June was included in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. RDIF has asked the health Ministry to allow the use of "Avifauna" outpatient those treated for the coronavirus of the house.
Brazil and Latin America, which sharply increases the number of people infected with coronavirus, the first to receive the drug "Aviewer," said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"We have received a request from more than 50 countries, and definitely a priority for us are those countries where sharply increasing number of coronavirus infections. This, of course, Brazil and many other Latin American countries," said Dmitriev in an interview via Skype on the channel "Russia 1".
The demand for shares in Detskiy Mir, the largest Russian retailer of children's goods, from foreign and Russian investors has exceeded the offer five times, more than 60% of the order book was signed by international funds from Europe, America and Asia, said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
Sistema and the Russian-Chinese investment Fund (RCIF established by the Russian direct investment Fund and China Investment Corporation) on Wednesday reported a successful SPO of the shares "Children's world". And RCIF sell of 15.94% of the shares will receive the securities order 10,953 billion. Share AFK "System" in the retailer after posting will be reduced to 20.38% from 33,38%, RCIF - to 4.62% from 7.56% in the aggregate they will retain 25% plus one share of the company.
Holding "national immunobiological company" the state Corporation "rostec" and the Russian direct investment Fund (RDIF) will begin to release drug based on blood plasma for the treatment of COVID-19, production is scheduled to deploy immediately on four grounds stated in the joint message of the companies.
"The partnership between RDIF and holding "national immunobiological company" involves the production of an immunoglobulin preparation that contains antibodies to the coronavirus SARS CoV-2. It will be made on the basis of plasma donors who have had coronavirus infection", - stated in the message.
Russian President Vladimir Putin discussed with the head of RDIF Kirill Dmitriev combating coronavirus and the establishment of test systems.
The President began a meeting with Dmitriev with the most relevant, according to him, the theme of the fight against the spread of coronavirus.
Russia manages to maintain the macroeconomic situation in the country at a good level, the inflation is kept within the parameters, and unemployment, though older, but not as dramatic as in other countries, said Russian President Vladimir Putin.
"Macroeconomics we are able to keep in working condition, very good quality level," Putin said at a meeting with head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
The Russian direct investment Fund (RDIF) and the RTP Global funds, Elbrus Capital, and Baring Vostok has set up a joint investment platform with the volume up to $ 200 million, which will support promising Russian companies affected by the impact of the pandemic coronavirus, the report said RDIF.
"The FUND, a sovereign Fund of the Russian Federation, and funds of RTP Global, Elbrus Capital, and Baring Vostok announced the creation of a joint investment platform with the volume up to $ 200 million. The platform will provide support for promising Russian companies in a wide range of industries that experienced negative effects of the pandemic coronavirus", - stated in the message.